Olvi-Vec Combined With Platinum Plus Etoposide Therapy in Patients With Late Phase SCLC

NCT07136285 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

SCLC, Extensive Stage

Interventions

DRUG: Olvi-Vec
DRUG: platinum (cisplatin or carboplatin)
DRUG: Etoposide

Sponsor

Newsoara HYK Biopharmaceutical (Shanghai) Co., Ltd.

Collaborators

[object Object]